Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum

European Journal of Neuroscience

Volumn 32, Issue 3, 2010, Pages 435-447

  Van Waes, Vincent ^a   Beverley, Joel ^a   Marinelli, Michela ^a   Steiner, Heinz ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

caudate putamen; immediate early gene; psychostimulant; rat

Indexed keywords

CITALOPRAM; COCAINE; FLUOXETINE; METHYLPHENIDATE; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZIF 268; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; DRUG POTENTIATION; FOREBRAIN; GENE CONTROL; GENE EXPRESSION REGULATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; CITALOPRAM; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; EARLY GROWTH RESPONSE PROTEIN 1; FLUOXETINE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; METHYLPHENIDATE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS;

EID: 77955162418     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07294.x     Document Type: Article

References (73)

1. Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G. Perrone-Capano, C. (2006a) Methylphenidate administration to adolescent rats determines plastic changes in reward-related behavior and striatal gene expression. Neuropsychopharmacology, 31, 1946 1956.
2. Adriani, W., Leo, D., Guarino, M., Natoli, A., Di Consiglio, E., De Angelis, G., Traina, E., Testai, E., Perrone-Capano, C. Laviola, G. (2006b) Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Ann. N Y Acad. Sci., 1074, 52 73.
3. Andersen, S.L. (2005) Stimulants and the developing brain. Trends Pharmacol. Sci., 26, 237 243.
4. Badiani, A., Oates, M.M., Day, H.E., Watson, S.J., Akil, H. Robinson, T.E. (1998) Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci., 18, 10579 10593.
5. Balcioglu, A. Wurtman, R.J. (1998) Dexfenfluramine enhances striatal dopamine release in conscious rats via a serotoninergic mechanism. J. Pharmacol. Exp. Ther., 284, 991 997.
6. Benloucif, S. Galloway, M.P. (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur. J. Pharmacol., 200, 1 8.
7. Benloucif, S., Keegan, M.J. Galloway, M.P. (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther., 265, 373 377.
8. Berke, J.D. Hyman, S.E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron, 25, 515 532.
9. Bhat, R.V. Baraban, J.M. (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther., 267, 496 505.
10. Bhatara, V., Feil, M., Hoagwood, K., Vitiello, B. Zima, B. (2004) National trends in concomitant psychotropic medication with stimulants in pediatric visits: practice versus knowledge. J. Atten. Disord., 7, 217 226.
11. Bogle, K.E. Smith, B.H. (2009) Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr. Drug Abuse Rev., 2, 157 176.
12. Borycz, J., Zapata, A., Quiroz, C., Volkow, N.D. Ferré, S. (2008) 5-HT(1B) receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology, 33, 619 626.
13. Brandon, C.L. Steiner, H. (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci., 18, 1584 1592.
14. Brandon, C.L., Marinelli, M., Baker, L.K. White, F.J. (2001) Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology, 25, 651 661.
15. Bubar, M.J. Cunningham, K.A. (2008) Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog. Brain Res., 172, 319 346.
16. Bubar, M.J., McMahon, L.R., De Deurwaerdère, P., Spampinato, U. Cunningham, K.A. (2003) Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology, 44, 342 353.
17. Carlezon, W.A.J. Konradi, C. (2004) Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology, 47, 47 60.
18. Castanon, N., Scearce-Levie, K., Lucas, J.J., Rocha, B. Hen, R. (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav., 67, 559 566.
19. Chase, T.D., Brown, R.E., Carrey, N. Wilkinson, M. (2003) Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats. Neuroreport, 14, 769 772.
20. Cotterly, L., Beverley, J.A., Yano, M. Steiner, H. (2007) Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a. Eur. J. Neurosci., 25, 3617 3628.
21. Csoka, A., Bahrick, A. Mehtonen, O.P. (2008) Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J. Sex. Med., 5, 227 233.
22. Ellinwood, E.H. Jr. Balster, R.L. (1974) Rating the behavioral effects of amphetamine. Eur. J. Pharmacol., 28, 35 41.
23. Everitt, B.J. Robbins, T.W. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci., 8, 1481 1489.
24. Fuchs, R.A., Branham, R.K. See, R.E. (2006) Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J. Neurosci., 26, 3584 3588.
25. Gardier, A.M., Moratalla, R., Cuellar, B., Sacerdote, M., Guibert, B., Lebrec, H. Graybiel, A.M. (2000) Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. J. Neurochem., 74, 1363 1373.
26. Graybiel, A.M. (1995) Building action repertoires: memory and learning functions of the basal ganglia. Curr. Opin. Neurobiol., 5, 733 741.
27. Graybiel, A.M., Canales, J.J. Capper-Loup, C. (2000) Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci., 23, S71 S77.
28. Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P. Farah, M.J. (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702 705.
29. Guerra, M.J., Liste, I. Labandeira-Garcia, J.L. (1998) Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Synapse, 28, 71 82.
30. Horner, K.A., Adams, D.H., Hanson, G.R. Keefe, K.A. (2005) Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion. Neuroscience, 131, 67 77.
31. Hyman, S.E. Nestler, E.J. (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry, 153, 151 162.
32. Ishii, M., Tatsuzawa, Y., Yoshino, A. Nomura, S. (2008) Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Psychiatry Clin. Neurosci., 62, 246.
33. Keefe, K.A. Horner, K.A. (2010) Neurotransmitter regulation of basal ganglia gene expression. In Steiner, H. Tseng, K.Y. (Eds Handbook of Basal Ganglia Structure and Function. Academic Press/Elsevier, London, pp. 461 490.
34. Kollins, S.H. (2008) ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J. Atten. Disord., 12, 115 125.
35. Kollins, S.H., MacDonald, E.K. Rush, C.R. (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav., 68, 611 627.
36. Kuczenski, R. Segal, D.S. (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem., 68, 2032 2037. (Pubitemid 27176139)
37. Lavretsky, H., Kim, M.D., Kumar, A. Reynolds, C.F. (2003) Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J. Clin. Psychiatry, 64, 1410 1414.
38. Le Nedelec, M.J. Rosengren, R.J. (2002) Methylphenidate inhibits cytochrome P450 in the Swiss Webster mouse. Hum. Exp. Toxicol., 21, 273 280.
39. Lin, J.S., Hou, Y. Jouvet, M. (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. Natl Acad. Sci. USA, 93, 14128 14133.
40. Lucas, J.J., Segu, L. Hen, R. (1997) 5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935. Mol. Pharmacol., 51, 755 763.
41. Mink, J.W. (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol., 50, 381 425.
42. Muller, C.P. Huston, J.P. (2006) Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol. Sci., 27, 105 112.
43. Nelson, J.C. (2007) Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies. CNS Spectr., 12 Suppl 22, 6 9.
44. Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci., 2, 119 128.
45. Packard, M.G. Knowlton, B.J. (2002) Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci., 25, 563 593.
46. Paxinos, G. Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
47. Randrup, A. Munkvad, I. (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia, 11, 300 310.
48. Ravindran, A.V., Kennedy, S.H., O'Donovan, M.C., Fallu, A., Camacho, F. Binder, C.E. (2008) Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry, 69, 87 94.
49. Redgrave, P. Gurney, K. (2006) The short-latency dopamine signal: a role in discovering novel actions? Nat. Rev. Neurosci., 7, 967 975.
50. Redgrave, P., Prescott, T.J. Gurney, K. (1999) The basal ganglia: a vertebrate solution to the selection problem? Neuroscience, 89, 1009 1023.
51. Safer, D.J., Zito, J.M. DosReis, S. (2003) Concomitant psychotropic medication for youths. Am. J. Psychiatry, 160, 438 449.
52. Sandson, N.B., Armstrong, S.C. Cozza, K.L. (2005) An overview of psychotropic drug-drug interactions. Psychosomatics, 46, 464 494.
53. See, R.E., Elliott, J.C. Feltenstein, M.W. (2007) The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology, 194, 321 331.
54. Steiner, H. (2010) Psychostimulant-induced gene regulation in corticostriatal circuits. In Steiner, H. Tseng, K.Y. (Eds Handbook of Basal Ganglia Structure and Function. Academic Press/Elsevier, London, pp. 501 525.
55. Steiner, H. Gerfen, C.R. (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res., 123, 60 76.
56. Steiner, H. Kitai, S.T. (2000) Regulation of rat cortex function by D1 dopamine receptors in the striatum. J. Neurosci., 20, 5449 5460.
57. Steiner, H., Van Waes, V. Marinelli, M. (2010) Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers? Biol. Psychiatry, 67, 592 594.
58. Sun, Z., Murry, D.J., Sanghani, S.P., Davis, W.I., Kedishvili, N.Y., Zou, Q., Hurley, T.D. Bosron, W.F. (2004) Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1. J. Pharmacol. Exp. Ther., 310, 469 476.
59. Swanson, J.M. Volkow, N.D. (2008) Increasing use of stimulants warns of potential abuse. Nature, 453, 586.
60. Torres, G. Rivier, C. (1993) Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res. Bull., 30, 173 176. (Pubitemid 23027207)
61. Unal, C.T., Beverley, J.A., Willuhn, I. Steiner, H. (2009) Long-lasting dysregulation of gene expression in corticostriatal circuits after repeated cocaine treatment in adult rats: effects on zif 268 and homer 1a. Eur. J. Neurosci., 29, 1615 1626.
62. Uslaner, J.M., Crombag, H.S., Ferguson, S.M. Robinson, T.E. (2003) Cocaine-induced psychomotor activity is associated with its ability to induce c-fos mRNA expression in the subthalamic nucleus: effects of dose and repeated treatment. Eur. J. Neurosci., 17, 2180 2186.
63. Vanderschuren, L.J., Di Ciano, P. Everitt, B.J. (2005) Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci., 25, 8665 8670.
64. Wang, J.Q. McGinty, J.F. (1996) Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In Merchant, K.M. (Ed Pharmacological Regulation of Gene Expression in the CNS. CRC, Boca Raton, pp. 81 113.
65. Weikop, P., Yoshitake, T. Kehr, J. (2007) Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur. Neuropsychopharmacol., 17, 658 671.
66. Wilens, T.E., Adler, L.A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., Utzinger, L. Fusillo, S. (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J. Am. Acad. Child Adolesc. Psychiatry, 47, 21 31.
67. Willuhn, I., Sun, W. Steiner, H. (2003) Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context. Eur. J. Neurosci., 17, 1053 1066.
68. Wirtshafter, D. Cook, D.F. (1998) Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats. Neuroreport, 9, 1217 1221.
69. Yano, M. Steiner, H. (2005a) Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience, 132, 855 865.
70. Yano, M. Steiner, H. (2005b) Topography of methylphenidate (Ritalin)-induced gene regulation in the striatum: differential effects on c-fos, substance P and opioid peptides. Neuropsychopharmacology, 30, 901 915.
71. Yano, M. Steiner, H. (2007) Methylphenidate and cocaine: the same effects on gene regulation? Trends Pharmacol. Sci., 28, 588 596.
72. Yano, M., Beverley, J.A. Steiner, H. (2006) Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience, 140, 699 709.
73. Zhu, H.J., Patrick, K.S., Yuan, H.J., Wang, J.S., Donovan, J.L., DeVane, C.L., Malcolm, R., Johnson, J.A., Youngblood, G.L., Sweet, D.H., Langaee, T.Y. Markowitz, J.S. (2008) Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am. J. Hum. Genet., 82, 1241 1248.